Toja Camba, F. J., García Quintanilla, L., Rodríguez Martínez, L., Tomine, J., Cajade-Pascual, F., Feitosa, C., . . . Fernández Ferreiro, A. (2023). Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA.
Citación estilo ChicagoToja Camba, Francisco Jose, et al. Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA. 2023.
Cita MLAToja Camba, Francisco Jose, et al. Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA. 2023.